Please login to the form below

Not currently logged in
Email:
Password:

medical affairs

This page shows the latest medical affairs news and features for those working in and with pharma, biotech and healthcare.

Vertex gains EU approval for earlier Orkambi use

Vertex gains EU approval for earlier Orkambi use

Development and Medical Affairs and Chief Medical Officer at Vertex. ... Reshma Kewalramani, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer, Vertex.

Latest news

More from news
Approximately 1 fully matching, plus 164 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    The company is rapidly establishing a European corporate infrastructure, led by Chief Operating Officer Chris Tovey, who is hiring staff in medical affairs, market access and marketing, and selecting candidates with

  • Why precision medicine demands precision engagement Why precision medicine demands precision engagement

    The continued advancement of treatment innovation requires that medical experts share their real-world experiences. ... This overcomes modern barriers and increases engagement across the sector. Finally, the cloud enables medical affairs teams to extend

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    Even the newest drugs will be covered based on exceptions for medical need, and preparing a market takes place on a horizon of years, not months. ... makers. Evidence will go more regional as well. Medical affairs teams will fuel a feedback loop from

  • Tackling a formidable foe Tackling a formidable foe

    Ali-Frederic Ben-Amor, Vice President, Global Medical Affairs for Neurology &Immunology, Merck. ... Ali-Frederic Ben-Amor, Vice President, Global Medical Affairs for Neurology &Immunology, Merck, epitomises the field’s passion and refusal to take a

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    Today he is executive vice president of Global Product &Portfolio Strategy (GPPS), Global Medical Affairs (GMA) and Corporate Affairs (CA), but he spent many years creating a long-term foundation for ... New collaborative culture. There have also been

More from intelligence
Approximately 5 fully matching, plus 30 partially matching documents found.

Latest appointments

  • Changes at Oxford PharmaGenesis, Synergy Vision and akt health communications Changes at Oxford PharmaGenesis, Synergy Vision and akt health communications

    Oxford PharmaGenesis has appointed Kevin Ryder (pictured above) as its new vice president, medical services. ... With over 16 years’ medical communication agency experience, Ryder has supported publication planning and other medical affairs activities.

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Rickard will become Verona’s new chief medical officer, and is expected to start her role next month. ... Previously, Dr. Rickard was vice president Clinical Development and Medical Affairs of GlaxoSmithKline’s Respiratory Medicines Development

  • imc, ROAD, Executive Insight and Life Healthcare adds to teams imc, ROAD, Executive Insight and Life Healthcare adds to teams

    Heading up the integrated medical affairs (ima) division is Neil Ravenhill, who becomes its global head of medical affairs and scientific strategy. ... and with ima we will be leveraging the shift in focus of the medical affairs role at pharma-biotech.

  • Industry appointments Industry appointments

    Pfizer Oncology loses its CMO to Allergan. Allergan has poached Pfizer Oncology’s chief medical officer Charles Hugh-Jones (pictured above) to serve as its senior vice president and chief medical ... officer. Hugh-Jones’ career has seen him work for

  • Weekly industry appointments Weekly industry appointments

    Gelesis adds to company. Biotech Gelesis has bolstered its offering with the addition of Harry Leider (pictured top right), former chief medical officer and group vice president of pharmacy company Walgreens. ... Leider’s new role as chief medical

More from appointments
Approximately 0 fully matching, plus 93 partially matching documents found.

Latest from PMHub

  • Lighthouse Visual Communications

    We provide a comprehensive range of digital consulting services throughout the pharmaceutical and healthcare brand lifecycle, for market access, medical affairs, brand and sales teams.

  • Porterhouse Medical US is celebrating its 1st Birthday!

    Part of the Porterhouse Medical Group – a globally-acclaimed scientific and medical communications network – Porterhouse Medical US is celebrating its 1st Birthday this week.Located in King of Prussia, PA, the ... We would like to thank those clients,

  • Bedrock scoops top prizes at Digital Awards

    The Bedrock team celebrated gold in the category Congress, Meetings and Events for their creative, integrated and engaging approach to Medical Affairs activities at ESC and ESC-HF for Novartis. ... before”, and that the ESC and ESC-HF Medical Affairs

  • Unlocking potential: How can pharma capitalise on its resources to support the NHS?

    Harnessing pharma’s rich educational assets. The McKinsey &Company report titled: ‘Medical Affairs: Key Imperatives for engaging and educating physicians in a digital world”, states that ‘81 percent of physicians are ... dissatisfied with their

  • New ICMJE Guidelines and their Impact on Biotech

    with a background in medical affairs and medical communications are often lacking. ... 3.  Author. Senior Vice President, Medical Strategy and Communications at Porterhouse Medical US.

More from PMHub
Approximately 0 fully matching, plus 35 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics